A Study of Blue Light Cystoscopy With Cysview® Registry

Overview

About this study

The purpose of this egistry study is to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  •  Adult >18 years old.
  • Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy, or undergoing surveillance cystoscopy for carcinoma of the bladder

Exclusion Criteria: 

  • Porphyria.
  • Gross hematuria.
  • Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Mark Tyson, M.D., M.P.H.

Open for enrollment

Contact information:

Mark Tyson M.D., M.P.H.

(480) 342-2804

Tyson.Mark@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20493011

Mayo Clinic Footer